text

China's inactivated COVID-19 vaccine shows promising results in two phase trials

BEIJING, June 17 (Xinhua) -- China has unveiled the results of the phase 1 and phase 2 clinical trials of an inactivated COVID-19 vaccine candidate, which shows promisi

text

'Major breakthrough' as UK scientists find cheap steroid cuts COVID-19 deaths

The drug, dexamethasone, reduced death rates by a third for patients on ventilators, and by a fifth for patients needing oxygen.

text

Moderna to begin phase-3 COVID-19 vaccine trial in July

U.S. biotech firm Moderna said on Thursday it expects to begin a phase-3 study of its COVID-19 vaccine candidate in July. Moderna has finalized the phase-3 study proto

text

Zhong Nanshan: COVID-19 vaccine could be available this fall

A COVID-19 vaccine could be put into emergency use as early as this fall, China's top respiratory expert Zhong Nanshan said during a live medical event with China's tech giant Baidu on Saturday.Na

text

G20 pledges over $21 bln to fight against COVID-19

Saudi Arabia, which holds the G20 presidency, announced in a statement on Saturday that G20 members and invited countries have committed to pledge more than 21 billion U.S. dollars to support the int

text

Japan aims to have coronavirus vaccines in use by June 2021

Japan aims to put coronavirus vaccines into use by June 2021, the health minister said on Friday, as the country strives to be fully ready to host the Tokyo Olympics, o

text

The Global Guardians: Chilean doctors use plasma to treat COVID-19

05:36 Raimundo Gacitua and Carolina Selman Bravo are doctors for the Arturo Lopez Perez Foundation in Santiago, Chile. At the end of March, they were inspired by the research made by C

text

W.H.O and partners launch a health technologies pool: COVID-19

As the world races to create a vaccine, the World Health Organization and partners have launched the COVID-19 Technology Access pool. It's an initiative aimed at making vaccines, tests, treatment

text

UN rights body supports WHO's leading role

The United Nations Human Rights Council adopted on Friday a President's Statement on human rights implications of the COVID-19. The Statement expressed concerns over the loss of life and livelih

text

China willing to share COVID-19 vaccines, medicines with world: premier

China is open to international cooperation on the research and development of vaccines, medicines and testing reagents for COVID-19, and is willing to share the deliverables with the world, Premie

text

EU, Japan call for solidarity, cooperation and multilateralism to defeat coronavirus

The leaders of the European Union and Japan said on Tuesday that global solidarity, cooperation, and effective multilateralism are required to defeat the coronavirus.

text

China to strengthen public health system development

China will strengthen the development of the public health system, according to a government work report submitted Friday to the national legislature for deliberation.

text

What have global scientists done since the coronavirus outbreak?

CGTN Virus and science have something in common: they do not recognize borders. Since the sudden outbreak of the novel coronavirus, scientists around the globe have been working round the cloc

text

Three COVID-19 vaccines in phase II clinical trials in Beijing

Three COVID-19 vaccines have entered phase II clinical trials in Beijing, a municipal health official said on Sunday.Xu Qiang, head of the Beijing Municipal Science and Technology Commission, said

text

Three COVID-19 vaccines in phase II clinical trials: Beijing health official

A staff member works in a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 10, 2020. (Xinhua/Zhang Yuwei)

text

Israeli university, Swiss firm team up to advance COVID-19 vaccine

Israel's Tel Aviv University (TAU) and Neovii, a Swiss-based biopharmaceutical company, announced on Thursday that they have signed an agreement to advance a patent-ba

text

Coronavirus vaccine takes at least one year: European Medicines Agency

A COVID-19 vaccine might be ready and available in at least one year, the Amsterdam-based European Medicines Agency (EMA) said on Thursday. "Vaccine development timelines are difficult to predict,